Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Dextrose, Steroid, PRP: Choosing the Right Injection for Long Term CRS Relief; a RCT

ID
Name
004AEstb/EC/01/2022
Description
USG guided injections to relieve carpal tunnel syndrome with dextrose water or steroid or PRP
Trial arms
Trial start
2023-10-10
Estimated PCD
2024-03-30
Trial end
2024-03-30
Status
Completed
Phase
Early phase I
Treatment
injection Dextrose water
dextrose will be injected around median nerve in wrist
Arms:
PRP, Steroid
Other names:
PRP
USG machine
usg guided nerve hydrdissection
Arms:
Dextrose, PRP, Steroid
Size
60
Primary endpoint
VAS
five to six months
Eligibility criteria
Inclusion Criteria: * NA Exclusion Criteria: * Na
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 60, 'type': 'ACTUAL'}}
Updated at
2024-04-05

1 organization

1 product

1 indication

Organization
Sheikh Zayed Medical College
Product
Dextrose Water
Indication
Carpal Tunnel Syndrome